ConductScience.org, home

Paper93183

Parenteral acyclovir therapy for herpesvirus infections in man.

Selby PJ and 13 others. Lancet, 1979. Cited by 203 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Parenteral acyclovir therapy for herpesvirus infections in man. Papers, record 93183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/93183

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Parenteral acyclovir therapy for herpesvirus infections in man.
PubMed
Journal
Lancet
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
203
iCite
Relative citation ratio, by iCite
9.6
iCite
Revised in PubMed
2019-06-10
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Selby PJP J
2Powles RLR L
3Janeson BB
4Kay HEH E
5Watson JGJ G
6Thornton RR
7Morgenstern GG
8Clink HMH M
9McElwain TJT J
10Prentice HGH G
11Corringharn RR
12Ross MGM G
13Hoffbrand AVA V
14Brigden DD

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
ChickenpoxMajor topic
GuanineMajor topic
Herpes SimplexMajor topic
Herpes ZosterMajor topic
Skin Diseases, InfectiousMajor topic
Adolescent
Adult
Aged
Child
Humans
Injections, Intravenous
Keratitis, Dendritic
Middle Aged
Neoplasms
Stomatitis, Herpetic

Source PubMed

Download CSV of topics

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.

PMIDTitleJournalYearIn PapersSource
38130345Clinical Review of Risk of Nephrotoxicity with Acyclovir Use for Treatment of Herpes Simplex Virus Infections in Neonates and Children.J Pediatr Pharmacol Ther2023https://conductscience.org/library/papers/38130345PubMed
34770975Critical Review of Synthesis, Toxicology and Detection of Acyclovir.Molecules2021https://conductscience.org/library/papers/34770975PubMed
33519948Nanotechnology for virus treatment.Nano Today2021https://conductscience.org/library/papers/33519948PubMed
32362789The road to new antiviral therapies.Clin Appl Immunol Rev2005https://conductscience.org/library/papers/32362789PubMed
28356666Acyclovir-induced thrombotic microangiopathy.Indian J Nephrol2017https://conductscience.org/library/papers/28356666PubMed
9018224Clinical investigators as critical determinants in pharmaceutical innovation.Nat Med1997https://conductscience.org/library/papers/9018224PubMed
7858927Viral infections in severely immunocompromised cancer patients.Support Care Cancer1994https://conductscience.org/library/papers/7858927PubMed
7427624Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.Br Med J1980https://conductscience.org/library/papers/7427624PubMed
7425614Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7425614PubMed
7305319Acyclovir treatment of experimental simian varicella infection of monkeys.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7305319PubMed
7028086Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers.Br J Ophthalmol1981https://conductscience.org/library/papers/7028086PubMed
7028083Topical acyclovir in herpes zoster ocular involvement.Br J Ophthalmol1981https://conductscience.org/library/papers/7028083PubMed
7014434Antiviral agents: an update--Part I.Indian J Pediatr1980https://conductscience.org/library/papers/7014434PubMed
7002049Bone marrow transplantation.Arch Dis Child1980https://conductscience.org/library/papers/7002049PubMed
7000209Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.Blut1980https://conductscience.org/library/papers/7000209PubMed
7000171Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.Br J Ophthalmol1980https://conductscience.org/library/papers/7000171PubMed
6893005Genital herpes.Br Med J1980https://conductscience.org/library/papers/6893005PubMed
6315332Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.Drugs1983https://conductscience.org/library/papers/6315332PubMed
6307134Susceptibility of bovid herpesvirus 1 to antiviral drugs: in vitro versus in vivo efficacy of (E)-5-(2-Bromovinyl)-2'-deoxyuridine.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6307134PubMed
6304151Problems of infection after bone marrow transplantation.J Clin Pathol1983https://conductscience.org/library/papers/6304151PubMed

See all 34 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/93183

GET https://conductscience.org/api/papers/v1/93183/cited_by?page=2